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Abstract
Purpose Parathyroid adenoma detection with dual-phase
99mTc-sestamibi (MIBI) scintigraphy depends on differential
MIBI washout from thyroid. However, autoimmune thyroid
disease (AITD) may cause MIBI to be retained in the thyroid
gland and reduce parathyroid detection. We evaluated the im-
pact of AITD onMIBI thyroid retention and additional benefit
of SPECT/CT in these patients.
Methods Dual phase planar MIBI and SPECT/CT was per-
formed on 82 patients. SPECT/CTwas performed immediate-
ly after delayed planar scan. Thyroid density (Hounsfield unit,
CT-HU) and size were measured on CT component of
SPECT/CT. MIBI uptake in early scans and retention in de-
layed scans were visually graded and correlated with clinical
factors and CT findings. Finally, planar and SPECT/CT find-
ings were compared for parathyroid lesion visualization ac-
cording to thyroid MIBI retention.
Results In early scan, multivariate analysis showed only thy-
roid size predicted early uptake. In delayed scan, multivariate
analysis showed higher visual grade in early scan, lower CT-
HU or AITD were significant predictors for delayed thyroid
parenchymal retention. Overall, ten more parathyroid lesions
were visualized on SPECT/CT compared to planar scans (57
vs. 47, p = 0.002). SPECT/CT was especially more useful in
patients with thyroidal MIBI retention, as eight out of the ten
additional lesions detected were found in patients with thyroid
MIBI retention.
Conclusion AITD is an important factor for MIBI thyroid
parenchymal retention on delayed scans, and may impede
parathyroid lesion detection. Patients with MIBI retention in
the thyroid parenchyma on delayed scans are likely to benefit
from an additional SPECT/CT.
Keywords Autoimmune thyroid disease . 99mTc-sestamibi
scintigraphy . SPECT/CT . Parathyroid
Introduction
Accurate preoperative localization of parathyroid adenomas or
hyperplasia has gained in importance as more patients opt for
minimally invasive parathyroid surgery. Compared to other
conventional imaging modalities such as ultrasonogram (US),
computed tomography (CT), and magnetic resonance (MR),
99mTc-2-methoxy-2-methylpropyl isonitrile (99mTc-sestamibi,
MIBI) parathyroid scintigraphy has been shown to have higher
sensitivity in detecting parathyroid adenomas [1, 2]. In addition,
the anatomical information provided by single positron emis-
sion computed tomography/computed tomography (SPECT/
CT) has improved the detection and localization of parathyroid
lesions compared to planar scans alone [3, 4].
Parathyroid visualization using dual phase parathyroid
scintigraphy protocol relies on differential washout of MIBI
from the thyroid parenchymawith parathyroid lesion retention
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on delayed planar images [5]. However, previous studies have
shown that MIBI is not equally washed out from the thyroid
gland for all patients on delayed images; focal thyroid disease
or amiodarone induced thyrotoxicosis has been reported to be
a factor for MIBI retention in the thyroid gland [6, 7]. Few
studies have attempted to evaluate factors ofMIBI retention in
the thyroid gland, and its impact on parathyroid lesion detec-
tion. We underwent this study to evaluate the usefulness of
SPECT/CT in evaluating parathyroid lesion detection in pa-
tients with thyroid parenchymal diseases.
The thyroid gland has the unique characteristic of high
attenuation in non-contrast CT scan due to its high iodine
content [8, 9]. Previous reports have shown that iodine content
decreases in autoimmune thyroid diseases (AITD), such as
Graves’ disease or Hashimoto thyroiditis, which can be reli-
ably detected with non-contrast CT [10–12]. The purpose of
this study was to correlate clinical and imaging findings with
MIBI retention in the thyroid gland, and to evaluate the addi-
tional benefit of SPECT/CT in parathyroid lesion detection in
patients with thyroidal MIBI retention.
Materials and Methods
Patients
We retrospectively reviewed hospital records of 86 patients
who were referred for dual phase MIBI parathyroid scintigra-
phy with SPECT/CT from November 2012 to May 2014 for
elevated parathyroid hormone (PTH) and/or serum calcium
levels. We excluded four patients who previously underwent
previous thyroidectomy beforeMIBI scan. Finally, 82 patients
were included in this study. Of these, 40 patients had under-
gone surgical exploration. All initial PTH levels were obtained
within 1 month of MIBI scintigraphy. All patients underwent
ultrasonogram for evaluation of parathyroid lesions, and
ultrasonogram scans was retrospectively reviewed by an ex-
perienced radiologist specialized in thyroid, and radiologic
findings of diffuse thyroid parenchymal disease were record-
ed. AITD was considered when patients had ultrasonogram
findings of diffuse thyroid parenchymal disease and positive
serum antithyroid autoantibodies or thyroid hormones levels
indicative of primary hyper/hypothyroidism [13]. The institu-
tional review board approved this study and informed consent
was waived for this retrospective study.
Imaging Protocol
All patients were injected intravenously with 740 MBq
± 20 MBq of MIBI. Early and planar delayed images were
acquired at 10 min and 2 h after radiotracer injection, and
multiple planar images were obtained: anterior, 20° right an-
terior oblique, and 20° left anterior oblique using a Symbia
TruePoint SPECT/CT (Siemens Healthcare, Knoxville, TN,
USA). Immediately after delayed planar imaged scan, we ob-
tained SPECT and CT images, and CT images were obtained
at 5 mm slice thickness, voltage of 110 kV, and current of
42 mA, with 512 × 512 matrix using standard filter. SPECT
images of the neck were acquired into 1.78× zoom, 128 × 128
matrix with step and shoot scan mode (32 frameset, 25 s per
frame, and 5.5° angles). SPECT image reconstruction was
performed with CT based attenuation correction and a
Hanning 3-dimensional post-filter (cut-off frequency, 0.85 cy-
cles/cm), with a 3D Flash iterative reconstruction (eight sub-
sets and eight iterations). The SPECTacquisition took approx-
imately 14min, whereas the CTacquisition took approximate-
ly 10–20 s.
Imaging Analysis
All planar images were retrospectively reviewed on dedicated
Syngo workstation (Siemens, VA60A software) by two expe-
rienced nuclear medicine physicians separately, and differ-
ences in opinion were resolved by consensus. In planar image
analysis, thyroid gland uptake in early planar images were
visually graded into three groups (E1:MIBI uptake lower than
the salivary gland, E2: MIBI uptake similar to the salivary
gland, and E3: higher uptake than the salivary gland)
(Fig. 1a–c). The delayed planar images were visually catego-
rized into two groups (D0: thyroid washout group, no thyroid
parenchyma visualization, and D1: thyroid retention group,
thyroid parenchymal visualization) (Fig. 1d–e). Patients were
grouped according to early uptake and delayed washout
patterns.
In CT scan image analysis, the Hounsfield units values of
the thyroid glands was measured by drawing three circular
region of interests (ROI) and recording the average of the
mean value of each Hounsfield unit (CT-HU). Thyroid gland
size (CT size) were calculated by semiautomatically drawing
an ROI manually around the thyroid parenchyma on each
axial CT scan image and automatically calculated thyroid size
using AW workstation (AW 4.4, GE Healthcare, Milwaukee,
WI, USA).
Finally, SPECT/CT scans were reviewed for parathyroid
visualization. SPECT/CT scans were reviewed by the same
two nuclear medicine physicians who were blinded to the
planar findings and other clinical factors. Positive parathyroid
lesion visualization was defined as nodular uptake higher than
thyroid parenchyma in the parathyroid lesion seen on CT
component of SPECT/CT. Differences in opinion were re-
solved by consensus.
Statistical Analysis
Chi-square test was performed to evaluate correlation between
early uptake with retention in delayed images. Univariate
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linear regression analysis was performed to evaluate the rela-
tionship between visual grade (E1, E2, and E3) from clinical
factors (age, sex, AITD, PTH, and serum calcium level) and
CT factors (CT-HU, and CT size). Multivariate analysis was
performed on the statistically significant factors in univariate
analysis. For delayed images, univariate logistic regression
analysis of the same clinical and CT factors as well as early
scan MIBI uptake (E1, E2, and E3) was used to predict MIBI
retention at 2 h delayed images (D1, and D2). Receiver oper-
ating characteristic (ROC) curve analysis was performed to
determine the CT-HU cut-off values with the highest sensitiv-
ity in predicting MIBI retention at delayed images.
Multivariate analysis was performed on the statistically signif-
icant factors in univariate analysis. McNemar’s test was per-
formed to compared parathyroid lesion detection for planar
and SPECT/CT according to thyroid MIBI retention.
Furthermore, subgroup analysis was performed in patients
who underwent surgical exploration to compared pathologi-
cally confirmed parathyroid lesions detection according to
thyroid MIBI retention using McNemar’s test. Software used
to perform these analyses was SPSS 20.0 (IBM Corp.,
Armonk, NY, USA). Statistical significance was defined by
a p value <0.05 for all statistical analysis.
Results
Patient Characteristics
A total of 82 patients (58 female; overall mean age 53.0
± 13.4 years old, range 23–81) were included in this study.
All patients had elevated PTH levels (414.6 ± 612.4 pg/ml,
normal range 15–65 pg/ml). Serum calcium levels were elevat-
ed in 35 patients (10.5 ± 1.5 mg/dl, range 7.9-17.2 mg/dl, nor-
mal range 8.5-10.5 mg/dl). Ultrasonogram findings of diffuse
thyroid parenchymal disease were seen in 36 patients (43.9 %)
and 42 patients (51.2 %) showed positive serum antithyroid
autoantibodies or primary hyper/hypothyroidism. A total of
21 (25.6 %) patients were positive in both studies, and consid-
ered to have AITD. Table 1 shows demographics of study
population.
Factors for MIBI Uptake in Early Scans and Retention
in Delayed Scan
Visual analysis of thyroid uptake and retention showed that
higher MIBI uptake on early planar images was correlated
with increased retention on delayed planar images
(p < 0.001, chi-squared test for trend) (Table 1). Most patients
with low early thyroid uptake (E1, n = 20) predominately
showed no retention on delayed scans (D0 = 16 patients,
80.0 %; D1 = 4 patient, 20.0 %). Patients that showed moder-
ate early thyroid uptake (E2, n = 50) showed similar propor-
tion of washout or retention pattern on delayed scans (D0 = 27
patients, 54.0 %; D1 = 23 patients, 46.0 %). All patients with
high early thyroid uptake (E3, n = 12) showed retention on
delayed images (D1 = 12, 100 %).
Univariate linear regression analysis for clinical factors (age,
sex, AITD, PTH, and serum calcium level) and CT factors (CT
size, and CT-HU) contributing to higher uptake during early
scan showed that larger CT size (p < 0.001), and lower CT-
HU (p = 0.044) were significant predictors of higher uptake at
early scan. Clinical factors such as age, sex, AITD, PTH, and
serum calcium level were not significantly correlated with
Fig. 1 Representative cases of
MIBI uptake and retention
patterns of the thyroid in early and
delayed planar images. Early
scans were graded into three
grades (a = E1, low; b = E2,
moderate; c = E3, high) and
delayed scans were graded in two
grades (d = D0, thyroid washout;
e = D1, thyroid retention)
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uptake in early scans (p = 0.134, p = 0.799, p = 0.195,
p = 0.392, and p = 0.247, respectively). Multivariate analysis
showed that only CT size was significant for higher uptake in
early scans (p = 0.001) (Table 2).
ROC analysis for CT-HU showed a cut–off of 92.6 as
highly specific (86.1 %) in detecting retention on delayed
images (area under the curve: 0.782, 95 % confidence interval
0.677–0.866, p < 0.001). Univariate analysis of factors con-
tributing to MIBI retention in delayed scan showed that larger
CT size, lower CT-HU, AITD, and higher intensity in early
scans were significant predictors for increased retention on
delayed scans (p = 0.002, p < 0.001, p = 0.004, and p < 0.001,
Table 2 Univariate and multivariate analysis in the prediction of MIBI thyroid parenchyma retention on early and delayed scans
Early scan
Factors Univariate Multivariate
B (95 % CI†) p-value B (95 % CI) p-value
CT size 0.017 (0.008–0.026) <0.001* 0.016 (0.006–0.025) 0.001*
CT-HU −0.006 (−0.012–−0.001) 0.044* −0.004 (−0.010–0.001) 0.134
Age 0.008 (−0.002–0.018) 0.134
Sex (male reference) 0.039 (−0.264–0.340) 0.799
AITD‡ 0.216 (−0.116–0.507) 0.195
PTH 0.000 (0.000–0.000) 0.392
Serum calcium 0.054 (−0.038–0.147) 0.247
Delayed scan
Factors Univariate Multivariate model 1 Multivariate model 2
OR§ (95 % CI) p-value OR (95 % CI) p-value OR (95 % CI) p-value
Early scan 7.122 (2.473–20.515) <0.001* 11.365 (2.727–47.375) 0.001* 7.130 (2.092–24.300) 0.002*
CT size 1.089 (1.032–1.150) 0.002* 1.064 (0.984–1.151) 0.119 1.066 (0.998–1.139) 0.057
CT-HUcat║ 9.867 (3.360–28.971) <0.001* 20.102 (4.339–93.122) <0.001*
Age 1.030 (0.996–1.066) 0.085
Sex (male reference) 0.871 (0.336–2.257) 0.776
AITD 5.287 (1.708–16.364) 0.004* 6.076 (1.432–25.787) 0.014*
PTH 1.000 (0.999–1.000) 0.285
Serum calcium 1.177 (0.866–1.600) 0.297
CI† = confidence interval; AITD‡ = autoimmune thyroid disease; OR§ = odds ratio; CT-HUcat║ =CT-HU categorized by 92.6 Hounsfield unit (HU)
cut-off
*statistically significant
Table 1 Patient demographics
and MIBI thyroid parenchyma
retention patterns
Early scan Delayed scan
Low (E1) Moderate
(E2)
High (E3) Washout
(D0)
Retention
(D1)
E1 washout n (%) 20 16 (80.0 %) 4 (20.0 %)
E2 washout n (%) 50 27 (54.0 %) 23 (46.0 %)
E3 washout n (%) 12 0 (0 %) 12 (100 %)
Mean HU† 107.3 ± 24.6 100.0 ± 20.7 91.3 ± 20.5 110.2 ± 19.6 89.8 ± 19.4
CT size (cm3) 14.3 ± 6.5 18.1 ± 10.5 33.2 ± 24.6 14.6 ± 5.9 24.6 ± 18.0
Age (years) 50.3 ± 14.5 53.0 ± 13.1 57.8 ± 12.3 50.6 ± 14.1 55.7 ± 12.1
PTH (ng/ml) 448.3 ± 499.6 446.5 ± 711.3 225.3 ± 174.8 485.0 ± 716.8 336.8 ± 468.7
Serum calcium (mg/dl) 10.2 ± 1.4 10.5 ± 1.5 10.9 ± 1.5 10.3 ± 1.2 10.6 ± 1.7
AITD‡ (yes:no) 5:15 10:40 6:6 5:38 16:23
Sex (female:male) 15:5 33:17 10:2 31:12 27:12
HU† =Hounsfield unit; AITD‡ = autoimmune thyroid disease
Continuous values are in mean value ± SD
Nucl Med Mol Imaging (2017) 51:32–39 35
respectively). Age, sex, PTH, and serum calcium level were
not significant for retention on delayed scans (p = 0.085,
p = 0.776, p = 0.285, and p = 0.297, respectively). Two models
for logistic multivariate analysis were done to evaluate for
MIBI retention on delayed scans due to the multi-
collinearity between CT-HU and AITD. Model 1 showed that
patients with low CT-HU (odds ratio (OR) = 20.102,
CI = 4.339–93.122, p < 0.001) and higher retention on early
scans (OR = 11.365, CI = 2.727–47.375, p = 0.001) signifi-
cantly predicted retention of delayed scans, but CT size did
not (p = 0.119). Model 2 showed that both early uptake on
early scans (OR = 7.130, CI = 2.092–24.300, p = 0.002) and
AITD (OR = 6.076, CI = 1.432–25.787, p = 0.014) significant-
ly predicted retention on delayed scans (Table 2).
Comparison of SPECT/CT and Planar Scans
in Parathyroid Pathology Detection According to Thyroid
MIBI Retention
To determine the effect of MIBI retention in the thyroid gland
in visualizing parathyroid lesions at the thyroid bed, delayed
scans and SPECT/CT scans were reviewed and parathyroid
lesion visibility was analyzed. SPECT/CTsignificantly detect-
ed more parathyroid lesions compared to planar scans
(McNemar test, p = 0.002). Overall, 57 lesions were seen on
delayed planar scans, which were all seen on SPECT/CT.
Additionally, ten more lesions were seen on SPECT/CT.
Twenty-five patients had no parathyroid lesions seen on both
planar and SPECT/CT scans.
Finally, comparison between planar and SPECT/CT in
parathyroid lesion detection according to thyroid MIBI reten-
tion was performed. In patients with thyroid MIBI washout
(D0 group, 43/82, 52.4 %), there was no significant difference
between SPECT/CT and planar scans in parathyroid lesion
detection (McNemar test p = 0.500, Table 3). Planar scans
detected 35 patients, whereas SPECT/CT detected 37 patients.
Both scans did not detect parathyroid lesions in six patients.
In the thyroid MIBI retention patients (D1 group, 39/82,
47.6 %), SPECT/CT detected significantly more parathyroid
lesions compared to planar scans (McNemar test p = 0.008,
Table 3). Planar scans detected only 12 parathyroid patients,
whereas SPECT/CT detected 20 parathyroid patients. Overall,
eight more patients were detected using SPECT/CT compared
to planar scans in the D1 group. Figure 2 shows representative
cases where thyroid parenchymal MIBI retention can lower
the sensitivity of parathyroid adenoma visibility. Note the mild
MIBI uptake in the parathyroid hyperplasia in Fig. 2b, which
is not much higher than the MIBI retention in the thyroid seen
in Fig. 2g.
Subgroup analysis was performed for 18 patients in thyroid
washout group (D0) and 22 patients in thyroid retention group
(D1) who underwent surgical exploration. A total of 40 le-
sions were pathologically confirmed in D0 group, and 45 le-
sions in D1 group. In patients with thyroid MIBI washout
group, planar scans detected 28 lesions (sensitivity per lesion,
70.0 %) and SPECT/CT scan detected 34 lesions (sensitivity
per lesion, 85.0 %) (McNemar test, p = 0.031, Table 4). In the
thyroid MIBI retention groups, planar scans detect 26 lesions
(sensitivity per lesion, 57.8 %), whereas SPECT/CT detected
36 lesions (sensitivity per lesion, 80.0 %) (McNemar test,
p = 0.002, Table 4).
Discussion
We have shown in our study that MIBI is retained in AITD
patients compared to patients without AITD. We have also
shown that the non-contrast CT component of SPECT/CT is
useful in predicting MIBI retention. Due to the high iodine
content of the thyroid parenchyma, the thyroid gland can be
well visualized on non-contrast CT (average HU of 107.0
± 18.3), whereas AITD such as Graves’ disease and
Hashimoto’s thyroiditis has lower iodine concentrations on
pathology, which is reflected as lower iodine content on
non-contrast CT (average HU of 81.6 ± 21.0) [9, 11, 12].
Taillefer et al. initially introduced the dual phase, single iso-
tope method usingMIBI to detect parathyroid adenomas. This
method relied on the more rapid washout of MIBI in the
Table 3 Comparison between delayed planar scan and SPECT/CT in parathyroid visibility according to MIBI thyroid parenchymal retention
Thyroid retention Parathyroid pathology visualization
D0 (thyroid washout, n = 43) SPECT/CT p-value*
Delayed planar scan Not visualized Visualized 0.500
Not visualized 6 2
Visualized 0 35
D1 (thyroid retention, n = 39) SPECT/CT p-value*
Delayed planar scan Not visualized Visualized 0.008
Not visualized 19 8
Visualized 0 12
*McNemar test
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thyroid than in pathologic parathyroid tissues [5]. Herein, we
have shown that MIBI washout is not the same in all patients
and that AITD is a significant factor for MIBI retention. This
finding is indirectly seen in previous studies that showed
MIBI retention in AITD patients on 30 min post-injection
images [14, 15].
Theoretically, retention of MIBI in the thyroid gland on
delayed images may be an important factor of reduced visibil-
ity of small parathyroid adenomas and, especially, parathyroid
hyperplasia; it may also be a significant contributing factor of
false negative results. In the present study, we have shown that
MIBI retention is an important factor of reduced sensitivity in
parathyroid detection in planar scans. In patients without thy-
roid MIBI retention, planar scans and SPECT/CT scans were
nearly totally concordant (35/37, 94.6 %). In patients with
MIBI retention, significantly more lesions were detected on
SPECT/CT compared to planar scans (20 vs. 12). This sug-
gests that SPECT/CT may be especially useful in reducing
false negative results on planar scans in patients with AITD
or thyroid MIBI retention.
Previous studies have shown a clear benefit of SPECT/CT,
with an increased sensitivity and accuracy over ultrasonogram
or planar scans alone, and especially in patients with concom-
itant nodular goiter [16, 17]. However, only one study has
Fig. 2 Representative cases of parathyroid visualization according to
MIBI retention in thyroid parenchyma. a–e A 26-year-old female
patient with parathyroid lesion visualization on delayed scans after
washout from thyroid parenchyma (a). Early scan showed mild thyroid
uptake (E1) (b). Delayed scan shows thyroid washout (D0), resulting in
two nodular lesions corresponding to parathyroid lesions (c–e). No
additional benefit in lesion detection on SPECT/CT. Black arrow
indicates parathyroid lesion, and white arrow indicates minimal MIBI
retention in the normal thyroid parenchyma (HU = 145.9). Final
pathology was parathyroid hyperplasia in both parathyroid lesions. f–j
A 53-year-old female patient with thyroid MIBI retention, resulting in
parathyroid lesion visualization only on SPECT/CT (f). Early scan
showed high uptake (E3) (g). Delayed scan shows thyroid retention
(D1). No parathyroid lesion was detected on planar scans (h–j).
Detection of parathyroid lesion on SPECT/CT only. Black arrow shows
parathyroid adenoma clearly seen onMIP and SPECT/CT fusion images.
White arrow depicts MIBI retention in the thyroid gland (HU = 96.3).
Final pathology was parathyroid adenoma
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specifically evaluated the effect of AITD on parathyroid lesion
detection. Our results are comparable to a recent study by Boi
et al. [13], who evaluated MIBI and ultrasonogram detection
rates of parathyroid lesions in patients with and without
AITD. They found that in patients with AITD, MIBI had a
very low sensitivity and specificity of 36 % and 42 %, respec-
tively, compared to 100 % accuracy in patients without clini-
cal or imaging evidence of AITD. Boi concluded that PTH
level analysis from fine needle aspiration of cytologic fluid
will be helpful in these patients. We suggest that an immediate
SPECT/CT may be a more efficient, and less stressful method
to evaluated for parathyroid lesion detection in patients with
known AITD or in patients with thyroid parenchymal reten-
tion on delated scans.
We showed in our study a significant contribution of
SPECT/CT over planar scans in detection of parathyroid le-
sions in patients with thyroid MIBI retention on planar scans.
One potential reason for increased detection of parathyroid
lesions in these patients is the differences in reconstruction
algorithms between planar and SPECT images. Planar scans
show the summation of all radiotracer activity in the thyroid
and parathyroid, and parathyroid lesions will not be detected
when focal MIBI uptake is not higher than the summation of
thyroid parenchymal MIBI retention. Whereas in axial
SPECT images, the focal MIBI uptake in the parathyroid le-
sion compared to the diffuse uptake in the thyroid parenchyma
may provide higher contrast for parathyroid visualization. The
CT component was also beneficial in that HU of parathyroid
adenomas are lower than thyroid parenchyma, which helps in
localization. Via our analyses, we discerned that higher MIBI
uptake during early scans significantly predicts MIBI reten-
tion on delayed scans, suggesting that these patients are more
likely to benefit from delayed SPECT/CT during delayed im-
aging. Clinically determined AITD also significantly predict-
ed MIBI retention on delayed scans, suggesting that the pres-
ence of AITDmay also be of use in pre-selecting patients who
will benefit from SPECT/CT. We can also infer from our re-
sults that SPECT/CT will be especially useful compared to
dual isotope parathyroid scintigraphy in patients with sub-
acute thyroiditis or chronic phase of Hashimoto’s thyroiditis.
These patients will have minimal 99mTc-pertechnetate uptake
in the thyroid gland, which also reduces the effectiveness of
99mTc-pertechnetate in subtracting 99mTc-sestamibi thyroid
parenchymal uptake.
Previous studies on thyroid pathology focused on thyroid
nodules retaining MIBI on delayed scans, resulting in false
positive results. This may be due to the high incidence of
concomitant multinodular goiters in patients with primary hy-
perparathyroidism [18], especially in post-menopausal wom-
en [19]. Considering that some parathyroid lesions do not
retain MIBI, whereas some thyroid gland nodules do retain
MIBI [20], selection of patients that will benefit from other
imaging modalities, such as SPECT/CT or dual isotope
methods, may be beneficial in reducing medical costs.
The limitations of this study were parathyroid lesions were
not all resected or biopsied, therefore, false positive and false
negative analysis was not possible. Further prospective studies
are warranted to evaluate the additional value of SPECT/CT in
patients with diffuse thyroid diseases.
Conclusion
AITD is an important factor for thyroid parenchymal retention
of MIBI on delayed scans, which results in reduced visibility
of parathyroid lesions. In patients with increased retention on
delayed scans, SPECT/CTwas shown to have additional ben-
efit in parathyroid lesion detection, compared to planar scans.
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